Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc.verified

RAFA

Price:

$0.051

Market Cap:

$4.48M

Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics. These are available in various formats such as injectable solutions, ampoules, pediatric suspensions, oral tablets, and capsules. Additionally, Rafarma develops and supplies treatments for injuries, ocular inflammatory conditions, and immunological ailments. In a collaborative effort with PlantEXT Ltd., the company is involved in the research and producti...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2012-12-11

Stock Exchange

OTC

Ticker

RAFA

The Enterprise Value as of June 2026 (TTM) for Rafarma Pharmaceuticals, Inc. (RAFA) is 4.40M

According to Rafarma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.40M. This represents a change of -29.89% compared to the average of 6.27M of the last 4 quarters.

Rafarma Pharmaceuticals, Inc. (RAFA) Historical Enterprise Value (quarterly & annually)

How has RAFA Enterprise Value performed in the past?

The mean historical Enterprise Value of Rafarma Pharmaceuticals, Inc. over the last ten years is 29.58M. The current 4.40M Enterprise Value has changed 1.39% with respect to the historical average. Over the past ten years (40 quarters), RAFA's Enterprise Value was at its highest in in the March 2021 quarter at 236.73M. The Enterprise Value was at its lowest in in the June 2024 quarter at 3.00M.

Quarterly (TTM)
Annual

Average

29.58M

Median

14.24M

Minimum

1.01M

Maximum

142.50M

Rafarma Pharmaceuticals, Inc. (RAFA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rafarma Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.17%

Maximum Annual Enterprise Value = 142.50M

Minimum Annual Increase = -68.86%

Minimum Annual Enterprise Value = 1.01M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20252.37M-66.68%
20247.12M-68.86%
202322.87M7.01%
202221.37M-65.18%
202161.37M-56.94%
2020142.50M333.85%
202032.85M3.17%
20191.01M-45.78%
20181.85M-25.74%
20142.50M49.58%

Rafarma Pharmaceuticals, Inc. (RAFA) Average Enterprise Value

How has RAFA Enterprise Value performed in the past?

The current Enterprise Value of Rafarma Pharmaceuticals, Inc. (RAFA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.79M

5-year avg

23.02M

10-year avg

29.58M

Rafarma Pharmaceuticals, Inc. (RAFA) Enterprise Value vs. Peers

How is RAFA’s Enterprise Value compared to its peers?

Rafarma Pharmaceuticals, Inc.’s Enterprise Value is greater than Pharmadrug Inc. (2.64M), less than Bio Essence Corporation (11.55M), less than StateHouse Holdings Inc. (145.92M), less than Revive Therapeutics Ltd. (13.12M), greater than Ubiquitech Software Corp. (3.03M), greater than Integrated Cannabis Solutions, Inc. (-3114674.00), greater than LiveWire Ergogenics, Inc. (4.21M), less than Resilient Healthcare Corp (0), less than Radient Technologies Inc. (0), greater than Thunder Energies Corporation (762.37K),

Build a custom stock screener for Rafarma Pharmaceuticals, Inc. (RAFA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rafarma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rafarma Pharmaceuticals, Inc. (RAFA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rafarma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Rafarma Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Rafarma Pharmaceuticals, Inc. (RAFA)?

What is the 3-year average Enterprise Value for Rafarma Pharmaceuticals, Inc. (RAFA)?

What is the 5-year average Enterprise Value for Rafarma Pharmaceuticals, Inc. (RAFA)?

How does the current Enterprise Value for Rafarma Pharmaceuticals, Inc. (RAFA) compare to its historical average?